Gabapentin Capsule
Product Images NDC 64380-869

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64380-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (F0697d39 1473 4df8 B955 8ad587c02c5f 01)

Cockcroft And Gault Equation (F0697d39 1473 4df8 B955 8ad587c02c5f 01)
This appears to be a formula used to calculate a patient's estimated creatinine clearance (CLCr). It takes into account the patient's age, weight, and serum creatinine levels. However, without more information or context, it is not possible to provide a more detailed description of what this formula is used for or how it is applied in a medical setting.*
FDA Label Image

Image (F0697d39 1473 4df8 B955 8ad587c02c5f 02)

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (F0697d39 1473 4df8 B955 8ad587c02c5f 03)

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (F0697d39 1473 4df8 B955 8ad587c02c5f 04)

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (F0697d39 1473 4df8 B955 8ad587c02c5f 04)
This text appears to be a chart or table with three treatment groups (placebo, 1800 mg/day of gabapentin, and 2400 mg/day of gabapentin) and a pain score measured over seven weeks. The title of the chart is "Mean Pain Score" and it is unclear what condition or type of pain this refers to. Without additional information or context, it is difficult to provide a more detailed description.*
FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (F0697d39 1473 4df8 B955 8ad587c02c5f 05)

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (F0697d39 1473 4df8 B955 8ad587c02c5f 05)
This is a chart showing the proportion of responders, patients with a 50% to 100% reduction in pain score, at the endpoint in controlled studies of Postherpetic neuralgia (PHN). The chart includes data from Study 1 and Study 2. There are different doses studied, FBO, GBF 3600, GBF 1800, and GBF 2400. The percentage of responders varies between 12% and 34%. The asterisk above the graph indicates that p<0.001.*
FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥ 12 Years Of Age With Partial Seizures (F0697d39 1473 4df8 B955 8ad587c02c5f 06)

FDA Label Image

Gabapentin Capsules 100mg (100S)

Gabapentin Capsules 100mg (100S)
Gabapentin Capsules is a prescription drug containing 100mg of Gabapentin USP. The medication guide should be dispensed to each patient by the pharmacist. The usual dosage is not available, and the complete prescribing information can be found in the accompanying teralure. The capsules should be stored at a temperature between 15°C to 30°C (59°F 10 86°F) and out of reach of children. The container should be tightly closed, and the contents should be dispensed in a tight light-resistant container with a child-resistant closure, as required. The product is manufactured by Strides Pharma Science Lid in India and distributed by Strides Pharma Inc in East Brunswick, NJ. NDC 64380-867-07.*
FDA Label Image

Gabapentin Capsules 300mg (100S)

Gabapentin Capsules 300mg (100S)
This is a product label for Gabapentin capsules. The capsules contain 300mg of Gabapentin and are intended for oral use. The medication should be stored at a temperature of 50°F to 86°F and kept out of reach of children. The label also includes information on the manufacturer, dosage instructions, and a warning to consult the medication guide before use.*
FDA Label Image

Gabapentin Capsules 400mg (100S)

Gabapentin Capsules 400mg (100S)
This appears to be a label for Gabapentin capsules in the USP form. It provides information on the recommended dosage, the container for storage, and the content of the capsules. The manufacturer is identified as Stides Pharma Science Ltd. However, there might be some typographical errors in the text as it is obtained via .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.